Data are from the largest multi-institutional study on robotic-assisted radical cystectomy (RARC) with totally intracorporeal neobladder urinary diversion.

The British pharmaceutical company said combinations for its Blenrep drug were evaluated in adults with relapsed or refractory multiple myeloma who have previously received at least one line of ...

TriSalus Life Sciences® Inc. (Nasdaq: TLSI) ("TriSalus" or the "Company"), a company working to improve outcomes for patients with solid tumors by combining innovative drug delivery, today announced ...

Fig 3 Patient-reported satisfaction and preferences for oncologic home-hospitalization compared with standard ambulatory care after 12 weeks of study participation: (A) satisfaction with ...

PDUFA date nears for GSK plc’s Blenrep (belantamab mafodotin), the U.S. FDA’s Oncologic Drugs Advisory Committee will decide ...

Dr. Michael Weber brings expertise in spine oncologic surgery to UConn Health Dr. Michael Weber is an internationally ...

Web sites of 29 safety net care coordination programs in 22 states were identified; 62% (n = 18) offered oncologic services. Programs were in 65% (n = 11) of states that did not expand Medicaid. Of ...

Rapid advances in cancer research, diagnostic testing, and targeted therapies are transforming the landscape of cancer diagnosis and care – helping to improve patient outcomes, but also increasing the ...

In recent years, the adoption of a multidisciplinary approach to the care of patients with cancer has changed the landscape of oncologic practice. Using this model, surgeons, oncologists ...